| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2009 | US20090036452 Taar1 ligands |
| 02/05/2009 | US20090036451 Chemical inducers of neurogenesis |
| 02/05/2009 | US20090036450 Pyrazole compounds and use thereof |
| 02/05/2009 | US20090036449 Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors |
| 02/05/2009 | US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 02/05/2009 | US20090036447 Compounds, Compositions and Methods |
| 02/05/2009 | US20090036446 treating diabetes, Alzheimer's disease, Parkinson's disease, attention deficit disorder, schizophrenia, epilepsy, narcolepsy, pain and headaches, comprising administering 5-Methyl-2-methoxymethyl-1-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-1H-indole |
| 02/05/2009 | US20090036445 Kinase inhibitors |
| 02/05/2009 | US20090036444 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| 02/05/2009 | US20090036443 6-cyclohexyl-5-phenyl-4H-thieno[3,2-b]pyrrole-2-carboxylic acid, used for inhibiting hepatitis C virus polymerase or prevention and treatment of hepatitis C viral infections |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036441 Indole Derivatives With Antitumor Activity |
| 02/05/2009 | US20090036440 Novel pyrimidine derivatives - 816 |
| 02/05/2009 | US20090036438 Five-membered heterocycles useful as serine protease inhibitors |
| 02/05/2009 | US20090036437 Pharmaceutical composition comprising phenoxazinium compound as an active ingredient |
| 02/05/2009 | US20090036436 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 02/05/2009 | US20090036435 Pharmaceutical Compounds |
| 02/05/2009 | US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/05/2009 | US20090036433 Heterocyclic Compounds, their Preparation and their Use as Antibacterials |
| 02/05/2009 | US20090036432 Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic |
| 02/05/2009 | US20090036431 Cytotoxic Agents Comprising New Tomaymycin Derivatives |
| 02/05/2009 | US20090036430 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 02/05/2009 | US20090036429 Hydroxypiperidine Derivatives and Uses Thereof |
| 02/05/2009 | US20090036428 Agent for treating or preventing digestive ulcer |
| 02/05/2009 | US20090036427 Substituted bicyclic pyrimidone derivatives |
| 02/05/2009 | US20090036426 CB1 antagonists and inverse agonists |
| 02/05/2009 | US20090036425 Substituted bicyclolactam compounds |
| 02/05/2009 | US20090036424 Association between hla-drbi*07 allele and susceptibily to increased levels of alat following ximelagatran administration |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/05/2009 | US20090036422 Monoamide derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036421 Pyrrole Derivative or Salt Thereof |
| 02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
| 02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
| 02/05/2009 | US20090036418 Pharmaceutical composition for treatment of cancer containing pyridylpyridazine or transition metal complex thereof as active ingredient |
| 02/05/2009 | US20090036417 Cochleates without metal cations as bridging agents |
| 02/05/2009 | US20090036416 Novel CXCR4 Antagonist and Use Thereof |
| 02/05/2009 | US20090036415 Identification and treatment of estrogen responsive prostate tumors |
| 02/05/2009 | US20090036414 Mesalamine Formulations |
| 02/05/2009 | US20090036413 Compositions, uses, and method of making wound care products from naturally occurring food ingredients |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090036411 Modulation of cell fates and activities by phthalazinediones |
| 02/05/2009 | US20090036410 Structured Phospholipids |
| 02/05/2009 | US20090036409 Novel inhibitors of chymase |
| 02/05/2009 | US20090036408 Compositions and methods for combination antiviral therapy |
| 02/05/2009 | US20090036406 Injection |
| 02/05/2009 | US20090036405 Method for blocking ligation of the receptor for advanced glycation end-products (rage) |
| 02/05/2009 | US20090036404 Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof |
| 02/05/2009 | US20090036403 Tunably Crosslinked Polysaccharide Compositions |
| 02/05/2009 | US20090036402 Use of compounds from centella asiatica |
| 02/05/2009 | US20090036401 Particulate-soluble glucan preparation |
| 02/05/2009 | US20090036400 Pharmaceutical Preparations for Treating the Consequences of Alcohol Abuse, Hepatitis, Pancreatitis, Alzheimer's Disease, Parkinson's Disease, Diabetes, Toxic Kidney Disease, Reperfusion Damage, Arteriosclerosis, and as an Antidote Against Environmental Toxins and Medicinal Intoxication |
| 02/05/2009 | US20090036399 Nucleoside derivatives for treating hepatitis c virus infection |
| 02/05/2009 | US20090036398 Human G-Protein Coupled Receptor (HETGQ23) |
| 02/05/2009 | US20090036397 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
| 02/05/2009 | US20090036396 RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS |
| 02/05/2009 | US20090036394 GRP 146 Receptor |
| 02/05/2009 | US20090036392 Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
| 02/05/2009 | US20090036391 Modulation of line-1 reverse transcriptase |
| 02/05/2009 | US20090036390 Compositions and methods for treating neoplastic diseases |
| 02/05/2009 | US20090036389 Polymeric Micelle Formulations of Hydrophobic Compounds and Methods |
| 02/05/2009 | US20090036388 Compounds |
| 02/05/2009 | US20090036387 Novel chemical entities affecting neuroblastoma tumor-initiating cells |
| 02/05/2009 | US20090036386 Heterobifunctional compounds for selectin inhibition |
| 02/05/2009 | US20090036385 Hair care preparation |
| 02/05/2009 | US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same |
| 02/05/2009 | US20090036372 treating obesity, diabetes, inflammation, or cancer in a mammal with a biosynthesized protein from culturing microorganisms of algae or bacteria; viral infections, oxidative stress, cardiovascular diseases, immune system disorders, metabolic disorders, HIV, or gastric reflux disease |
| 02/05/2009 | US20090036371 Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents |
| 02/05/2009 | US20090036369 Anti-tumor agents comprising r-spondins |
| 02/05/2009 | US20090036362 Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof |
| 02/05/2009 | US20090036356 Octanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 02/05/2009 | US20090036355 Antisense Modulation of PTP1B Expression |
| 02/05/2009 | US20090036354 Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 02/05/2009 | US20090036352 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 02/05/2009 | US20090036348 Use of Novel HNF4a Target Genes and Their Gene Products |
| 02/05/2009 | US20090035771 gene expression; probes, primers, antibodies |
| 02/05/2009 | US20090035752 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not |
| 02/05/2009 | US20090035714 Methods and systems for concurrent tooth repositioning and substance delivery |
| 02/05/2009 | US20090035403 Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof |
| 02/05/2009 | US20090035395 Spondias mombin l. extract and methods of extracting and using such extract |
| 02/05/2009 | US20090035394 Use of dna-pk inhibition to sensitise atm deficient cancers to dna-damaging cancer therapies |
| 02/05/2009 | US20090035393 Fast acting inhibitor of gastric acid secretion |
| 02/05/2009 | US20090035392 User-adjustable treatment methods, systems and compositions for treating acne |
| 02/05/2009 | US20090035391 Nasal Irrigation Solutions And Methods Of Using Same |
| 02/05/2009 | US20090035389 Targeted protein cages |
| 02/05/2009 | US20090035388 Antimicrobial photo-stable coating composition |
| 02/05/2009 | US20090035385 Compositions including iron |
| 02/05/2009 | US20090035379 Fenofibrate compositions |
| 02/05/2009 | US20090035377 Composition and method for controlling drug delivery from silicone adhesive blends |
| 02/05/2009 | US20090035375 Pharmaceutical compositions for acute glucocorticoid therapy |
| 02/05/2009 | US20090035373 Pharmaceutical composition for contraception and blood pressure regulation, kit for contraception containing same and method of production of same |
| 02/05/2009 | US20090035372 method for manufacturing a pharmaceutical composition for controlled release of an active substance |
| 02/05/2009 | US20090035370 Dosage form and method of use |
| 02/05/2009 | US20090035369 Composition and Methods for Treating and Preventing Age-Related Macular Degeneration |
| 02/05/2009 | US20090035368 Embedded micellar nanoparticles |
| 02/05/2009 | US20090035367 Controlled degradation of expandable polymers in gastric volume reduction treatment |
| 02/05/2009 | US20090035366 Nanoparticulate benzothiophene formulations |
| 02/05/2009 | US20090035364 Para-substituted 2-alkoxyphenol compounds |
| 02/05/2009 | US20090035362 Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss |
| 02/05/2009 | US20090035357 Method of drug delivery using a transdermal device having a phase change material |
| 02/05/2009 | US20090035356 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |